Copper Complexes with Aminoglycoside Antibiotics and Their Toxicity
Author Information
Author(s): Wojciech Szczepanik, Piotr Kaczmarek, Malgorzata Je+/-owska-Bojczuk
Primary Institution: Faculty of Chemistry, University of Wroclaw
Hypothesis
The study investigates the oxidative activity of copper(II) complexes with aminoglycoside antibiotics and their potential toxicity.
Conclusion
Copper(II) complexes of aminoglycoside antibiotics may act as genotoxic agents and influence the biological activity of these drugs.
Supporting Evidence
- The study found that aminoglycoside antibiotics effectively bind copper(II) ions at physiological pH.
- Copper(II) complexes were shown to generate reactive oxygen species that can damage DNA.
- The complexes may induce the production of inflammatory cytokines in human immune cells.
- Neomycin B and kanamycin B were identified as particularly toxic aminoglycosides.
Takeaway
This study shows that certain antibiotics can bind to copper, which might make them harmful by causing damage to DNA and other important molecules in our body.
Methodology
The study used cyclic voltammetry, kinetic studies, and various bioassays to investigate the interactions and effects of copper(II) complexes with aminoglycoside antibiotics.
Limitations
The study does not address the long-term effects of these complexes in vivo or their interactions in complex biological systems.
Want to read the original?
Access the complete publication on the publisher's website